We serve Chemical Name:dimboa CAS:15893-52-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:dimboa
CAS.NO:15893-52-4
Synonyms:2,4-dihydroxy-7-methoxybenzoxazin-3-one;2,4-Dihydroxy-7-methoxy-1,4-benzoxazinone;2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one;2,4-dihydroxy-7-methoxy-2H-1,4-benzoxazin-3-one;2H-1,4-BENZOXAZIN-3(4H)-ONE,2,4-DIHYDROXY-7-METHOXY;2,4-Dihydroxy-7-methoxy-(2H)-1,4-benzoxazin-3(4H)-one
Molecular Formula:C9H9NO5
Molecular Weight:211.17100
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:461.3ºC at 760mmHg
Density:1.589g/cm3
Index of Refraction:1.658
PSA:79.23000
Exact Mass:211.04800
LogP:0.19320
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2,4-dihydroxy-7-methoxybenzoxazin-3-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,4-Dihydroxy-7-methoxy-(2H)-1,4-benzoxazin-3(4H)-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one Use and application,2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one technical grade,usp/ep/jp grade.
Related News: In approving the first new Alzheimer’s drug in nearly 20 years, the U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows new therapies onto the market without strong evidence that they work, regulatory and scientific experts say. dimboa manufacturer In approving the first new Alzheimer’s drug in nearly 20 years, the U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows new therapies onto the market without strong evidence that they work, regulatory and scientific experts say. dimboa supplier ICIG companies currently employ more than 3,000 people and operate 15 manufacturing facilities in Europe and the United States. dimboa vendor “Whenever a company hires outside counsel to conduct an inquiry, it’s taken extremely seriously by the Justice Department,” said Paul Pelletier, a former long-time federal prosecutor who used to oversee criminal investigations of corporations. dimboa factory In approving the first new Alzheimer’s drug in nearly 20 years, the U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows new therapies onto the market without strong evidence that they work, regulatory and scientific experts say.
